Khondrion, a clinical-stage pharmaceutical company discovering and developing therapies targeting mitochondrial disease, recently sat down with Kasey Woleben, Co-founder, and Sophia Zilber, Board Member and Patient Registry Director of Cure Mito Foundation, to talk about their work and the important role patients play in the research and development of potential new therapies for mitochondrial diseases, particularly via patient registries.
Understanding SURF1 Leigh Syndrome